Enhancing Clinical Trials Through Synergistic Gamma Power Analysis
Sokichi Honda1, Mitsuyuki Matsumoto1, Katsunori Tajinda1
1Neuroscience, La Jolla Laboratory, Astellas Research Institute of America LLC, San Diego, CA, United States.
Frontiers in Psychiatry
|June 27, 2020
Summary
Aberrant sensory processing, particularly gamma oscillations, is implicated in neuropsychiatric disorders. Analyzing baseline and evoked gamma activity using electroencephalography aids in drug development and patient response assessment.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Neuropsychiatric disorders often involve unknown etiologies, with aberrant sensory processing emerging as a key factor.
- Electroencephalography (EEG) is crucial for understanding the physiological basis of these disorders and evaluating new drug efficacy.
- Gamma band oscillations, a type of high-frequency brain activity, are frequently altered in patients with neuropsychiatric conditions.
Purpose of the Study:
- To explore the role of baseline and evoked gamma oscillations in neuropsychiatric disorders.
- To highlight the utility of EEG-based gamma analysis in drug development and patient stratification.
- To propose a comprehensive analytical approach combining baseline and evoked gamma measures.
Main Methods:
- Utilizing electroencephalography (EEG) to measure high-frequency oscillations in the gamma band.
- Differentiating between baseline gamma activity and evoked (time-locked) gamma responses.
- Analyzing gamma oscillations for insights into disease state and drug effects.
Main Results:
- Baseline gamma analysis serves as a surrogate for pharmacodynamics and predicts drug effects over time.
- Altered evoked gamma power can function as a disease biomarker and assess patient response to novel therapeutics.
- Both baseline and evoked gamma analyses offer complementary insights into clinical and translational medicine.
Conclusions:
- Comprehensive analysis of both baseline and evoked gamma oscillations can enhance drug development workflows.
- Integrating these complementary EEG techniques provides more accurate criteria for testing investigational new drugs.
- Gamma oscillation analysis holds significant potential for advancing the understanding and treatment of neuropsychiatric disorders.
Keywords:
Auditory Steady State Response (ASSR)autism spectrum disorder (ASD)baseline gammabipolar disorderelectroencephalography (EEG)evoked gammaschizophreniaMore Related Videos
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
3.1K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.6K
Related Concept Videos
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
309
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
309
01:22Dose-Response Relationship: Potency and Efficacy
6.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.1K
01:27Combined Effects of Drugs: Synergism
6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.6K